Mayssa Attar, PhD

Mayssa Attar is an accomplished executive with more than two decades of leadership experience in the biopharmaceutical and device industries. She has made significant contributions to the development, registration and/or commercialization of more than a dozen approved therapies. She joined Bausch and Lomb in May 2023 in the role of Senior Vice President, Global Pharmaceutical and Consumer Product R&D Head. Prior to her current role, Mayssa was at AbbVie as the Vice President of Research, Nonclinical and Translational Sciences Eye Care, Neurotoxins and Aesthetics at AbbVie. At AbbVie, Mayssa was awarded the title of Senior Research Fellow in recognition of her scientific contributions to advance science for patients. Mayssa began her industry career at Allergan where she spent more than 20 years and assumed roles of increasing responsibility where she became the Global Head of Nonclinical and Clinical Pharmacology overseeing the entire portfolio.
Dr. Attar has over 30-peer reviewed publications, more than 10 issued patents and is an invited national and international speaker. Mayssa has served as adjunct faculty at USC School of Pharmacy and as a board member for the Allergan Foundation and the Greater Irvine Chamber of Commerce.

Dr. Attar earned her Bachelor of Science with Honors and Masters of Science in Biochemistry from the University of Ottawa, Canada. Under the mentorship of Vincent HL Lee, a pioneer in drug delivery, Mayssa earned her PhD in Pharmaceutical Sciences from the University of Southern California. Mayssa is a Diplomate of the American Board of Toxicology.